Cardium Therapeutics (NYSE MKT: CXM), a health sciences and regenerative medicine company focused on unlocking the value in medical assets, has made significant progress over the past year in developing its unique gene therapy targeting heart disease, wound care solution for diabetic foot ulcers, and other products that it will feature at the Biotech Showcase